Proassurance CORP Form 4 insider transactions

ProAssurance Corporation's merger with The Doctors Company has been finalized, with common stock and deferred shares converted into a cash payout of $25 per share.

ProAssurance Corporation's merger with The Doctors Company subsidiary has been finalized, resulting in the conversion of director deferred stock into cash payments.

ProAssurance Corporation's merger with The Doctors Company subsidiary, Jackson Acquisition Corporation, has been finalized, resulting in Bruce D. Angiolillo's beneficial ownership of common stock being converted to cash.

ProAssurance Corporation's merger with The Doctors Company has been finalized, with Director Katisha T. Vance reporting transactions related to her holdings.

ProAssurance Corporation's merger with The Doctors Company subsidiary, Jackson Acquisition Corporation, has been finalized, converting outstanding common stock and deferred shares into cash payments.

ProAssurance Corporation's merger with The Doctors Company has been finalized, resulting in executive Dana S. Hendricks' beneficial ownership of common stock being converted to cash.

ProAssurance Corporation's merger with The Doctors Company subsidiary has been finalized, with shareholders receiving $25.00 per share in cash and outstanding restricted stock units vesting and being cashed out.

ProAssurance Corporation's merger with The Doctors Company subsidiary, Jackson Acquisition Corporation, has been finalized, with shareholders receiving $25.00 per share in cash.

ProAssurance Corporation's merger with The Doctors Company has been finalized, resulting in the conversion of director deferred stock into cash payments.

ProAssurance Corporation's merger with The Doctors Company has been finalized, with director Samuel A. Di Piazza Jr. reporting the conversion of his deferred shares into cash consideration.

ProAssurance Corporation's merger with The Doctors Company has been finalized, converting outstanding common stock and deferred shares into cash payments of $25.00 per share.

ProAssurance Corp's merger with The Doctors Company has been finalized, with Executive VP Noreen Dishart reporting a transaction involving her beneficial ownership of common stock and restricted stock units.

ProAssurance Corporation's merger with The Doctors Company subsidiary has been finalized, resulting in executive stock unit conversions and cash payouts.

ProAssurance Corporation's merger with The Doctors Company has been finalized, resulting in a cash payout of $25 per share and adjustments to executive beneficial ownership.

Noreen Dishart, Executive VP/Chief HR Officer at ProAssurance Corp, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.

ProAssurance Corp. President of Healthcare Professional Liability, Robert David Francis, reported the vesting and settlement of Restricted Stock Units, resulting in both acquisition and disposition of common stock.

ProAssurance CFO Dana S. Hendricks reported the vesting and settlement of Restricted Stock Units, resulting in both acquisition and disposition of common stock.

ProAssurance Corporation's President and CEO, Edward L. Rand Jr., acquired common stock through the vesting of restricted stock units and simultaneously disposed of shares to cover tax obligations.

Kevin M. Shook, President of a ProAssurance subsidiary, reported the settlement of Restricted Stock Units and subsequent tax-related share disposition.

ProAssurance Executive Vice-President Jeffrey P. Lisenby reported the vesting and settlement of Restricted Stock Units into common stock and a subsequent tax-related share disposition, effective February 25, 2026.

ProAssurance Corporation's Executive Vice-President, Secretary & General Counsel, Jeffrey P. Lisenby, was granted 23,720 Restricted Stock Units, vesting over three years.

ProAssurance Corporation's President and CEO, Edward L. Rand Jr., was granted 95,714 Restricted Stock Units, vesting over three years.

ProAssurance Corporation's Chief Financial Officer, Dana S. Hendricks, was granted 23,720 restricted stock units, vesting over three years.

ProAssurance Corporation's subsidiary President, Kevin Merrick Shook, received a new grant of 23,720 Restricted Stock Units, adding to existing equity holdings.

ProAssurance Corp's Executive VP/Chief HR Officer, Noreen Dishart, received a new grant of 18,477 Restricted Stock Units with a vesting schedule extending to 2029.

ProAssurance Corporation's President of Healthcare Professional Liability, Robert David Francis, was granted 23,720 Restricted Stock Units.

ProAssurance Corporation's President and CEO, Edward L. Rand Jr., reported the vesting of 29,666 Restricted Stock Units (RSUs) and the subsequent disposition of 12,564 shares to cover tax obligations, increasing his direct beneficial ownership by 17,102 shares.

Jeffrey P. Lisenby, Executive Vice-President, Secretary & General Counsel of ProAssurance Corporation, reported the acquisition of 7,686 shares of common stock upon the vesting of Restricted Stock Units and the subsequent disposition of 3,256 shares for tax withholding purposes.

ProAssurance Corporation's Chief Financial Officer, Dana S. Hendricks, reported the vesting of 7,686 Restricted Stock Units (RSUs) and the subsequent disposition of 3,256 shares for tax purposes on May 23, 2025.

Kevin Merrick Shook, President of a ProAssurance Corp subsidiary, reported the acquisition of common stock through Restricted Share Unit vesting and a subsequent sale to cover tax obligations.